相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Aprepitant Promotes Caspase-Dependent Apoptotic Cell Death and G2/M Arrest through PI3K/Akt/NF-κB Axis in Cancer Stem-Like Esophageal Squamous Cell Carcinoma Spheres
Hossein Javid et al.
BIOMED RESEARCH INTERNATIONAL (2021)
Investigation of the Role of Neurokinin-1 Receptor Inhibition Using Aprepitant in the Apoptotic Cell Death through PI3K/Akt/NF-κB Signal Transduction Pathways in Colon Cancer Cells
Atefeh Ghahremanloo et al.
BIOMED RESEARCH INTERNATIONAL (2021)
The Effect of SP/NK1R on the Expression and Activity of Catalase and Superoxide Dismutase in Glioblastoma Cancer Cells
Faranak Korfi et al.
BIOCHEMISTRY RESEARCH INTERNATIONAL (2021)
Substance P receptor blocker, aprepitant, inhibited cutaneous and other neurogenic inflammation side effects of the EGFR1-TKI, erlotinib
Joanna J. Chmielinska et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2020)
The role of substance P/neurokinin 1 receptor in the pathogenesis of esophageal squamous cell carcinoma through constitutively active PI3K/Akt/NF-κB signal transduction pathways
Hossein Javid et al.
MOLECULAR BIOLOGY REPORTS (2020)
Lipid Peroxidation Plays an Important Role in Chemotherapeutic Effects of Temozolomide and the Development of Therapy Resistance in Human Glioblastoma
Wei Wu et al.
TRANSLATIONAL ONCOLOGY (2020)
TGF beta regulates NK1R-Tr to affect the proliferation and apoptosis of breast cancer cells
Lushan Wang et al.
LIFE SCIENCES (2020)
The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid Leukemia
Miguel Munoz et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The Role of Tachykinins in the Initiation and Progression of Gastrointestinal Cancers: A Review
Pedram Hashemian et al.
INTERNATIONAL JOURNAL OF CANCER MANAGEMENT (2020)
SP promotes cell proliferation in esophageal squamous cell carcinoma through the NK1R/Hes1 axis
Fei Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
The thioredoxin system and cancer therapy: a review
Fariba Mohammadi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
The emerging role of substance P/neurokinin-1 receptor signaling pathways in growth and development of tumor cells
Hossein Javid et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2019)
Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload
Chentao Ge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Redox-Mediated Mechanism of Chemoresistance in Cancer Cells
Eun-Kyung Kim et al.
ANTIOXIDANTS (2019)
Oxidative stress response induced by chemotherapy in leukemia treatment
Jin Zhang et al.
MOLECULAR AND CLINICAL ONCOLOGY (2018)
Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis
Susmit Suvas
JOURNAL OF IMMUNOLOGY (2017)
Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review
Ron Batash et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Antitumor action of temozolomide, ritonavir and aprepitant against human glioma cells
Richard E. Kast et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Relapsed Glioblastoma: Treatment Strategies for Initial and Subsequent Recurrences
Alicia Tosoni et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)
Inhibition of tachykinin NK1 receptor using aprepitant induces apoptotic cell death and G1 arrest through Aktip53 axis in pre-B acute lymphoblastic leukemia cells
Samaneh Bayati et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Evaluation of Matrix Metalloproteinases, Cytokines and Their Potential Role in the Development of Ovarian Cancer
Mahmood Rasool et al.
PLOS ONE (2016)
The substance PINK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs
Miguel Munoz et al.
JOURNAL OF BIOSCIENCES (2015)
Oxidative stress and autophagy: the clash between damage and metabolic needs
G. Filomeni et al.
CELL DEATH AND DIFFERENTIATION (2015)
ROS Function in Redox Signaling and Oxidative Stress
Michael Schieber et al.
CURRENT BIOLOGY (2014)
Antitumor activity of neurokinin-1 receptor antagonists in MG-63 human osteosarcoma xenografts
Miguel Munoz et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer
Miguel Munoz et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo
Michael Berger et al.
JOURNAL OF HEPATOLOGY (2014)
Glioblastoma Multiforme: A Look Inside Its Heterogeneous Nature
Maria-del-Mar Inda et al.
CANCERS (2014)
Dietary total antioxidant capacity and gastric cancer risk in the European prospective investigation into cancer and nutrition study
Mauro Serafini et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Cancer chemotherapy reduces plasma total polyphenols and total antioxidants capacity in colorectal cancer patients
R. Santiago-Arteche et al.
MOLECULAR BIOLOGY REPORTS (2012)
Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting
Richard Hargreaves et al.
PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: WINNERS AND FINALIST CANDIDATES OF THE PRIX GALIEN USA, INTERNATIONAL, AND PRO BONO HUMANITARIAN AWARDS 2010 (2011)
Relationship between DNA damage and total antioxidant capacity in patients with glioblastoma multiforme
S. Tuzgen et al.
CLINICAL ONCOLOGY (2007)
Neuroprotective role of neurokinin B (NKB) on β-amyloid (25-35) induced toxicity in aging rat brain synaptosomes:: Involvement in oxidative stress and excitotoxicity
AK Mantha et al.
BIOGERONTOLOGY (2006)
ROS stress in cancer cells and therapeutic implications
H Pelicano et al.
DRUG RESISTANCE UPDATES (2004)
Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting - Results from a randomized, double-blind, placebo-controlled trial in Latin America
S Poli-Bigelli et al.
CANCER (2003)
Lipid hydroperoxide-mediated DNA damage
IA Blair
EXPERIMENTAL GERONTOLOGY (2001)